Bristol Myers’ bladder cancer drug meets goal in late stage sub-study

(Reuters) – Bristol-Myers Squibb Co said on Tuesday its drug in combination with chemotherapy met a dual main goal in a late-stage trial in patients with a type of bladder cancer.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini Ganguli)